Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: SVY, SCZ

US Home Healthcare Market (Services, Equipment & Software): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)


NEW YORK, May 4, 2020 /PRNewswire/ -- The US home healthcare market is forecasted to reach US$133.1 billion in 2024, recording growth at a CAGR of 5% during the period spanning 2020-2024. The growth in the market was supported by various factors like surging aged population, increasing obese population, rising personal disposable income of the individuals and declining elderly support ratio. The market experienced certain challenges such as training requirements of the service providers and long-term health care as burdensome. The market growth is expected to be driven by the growing prevalence of chronic diseases and increasing adoption of digitalization.

Read the full report: https://www.reportlinker.com/p05890411/?utm_source=PRN

The US home healthcare market can be segmented as follows: services, equipment and software. In 2019, the highest share of the market was held by services segment, followed by equipment and software. The US home care market by service type can be segmented as follows: rehabilitation services, unskilled home care, respiratory therapy services, infusion therapy services and telemetry. The dominant share of the market was held by rehabilitation services, followed by unskilled home care services. The US home care market by mode of payment can be segmented into the following four categories: medicare, medicaid, self-payment mode and private insurance. In 2019, the dominant share of the market was held by medicare, followed by medicaid.

The US home healthcare market by equipment can be divided into the following seven segments: diabetic care unit, BP monitors, multi-para diagnostic monitor, home pregnancy & fertility kits, apnea and sleep monitors, holter monitors and heart rate meters. In 2019, the dominant share of the market was held by diabetic care unit, followed by BP monitors.

Scope of the report:

? The report provides a comprehensive analysis of the US home healthcare market with potential impact of COVID-19.
? The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
? The competitive landscape of the market, along with the company profiles of leading players (AdaptHealth corp, Addus Home Care, Amedisys, Ensign Group, LHC Group and Encompass Health) are also presented in detail.

Key Target Audience:

? Home Care Providers
? Home Medical Equipment/Software Manufacturers
? End Users (Businesses/Consumers)
? Investment Banks
? Government Bodies & Regulating Authorities

Read the full report: https://www.reportlinker.com/p05890411/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker


These press releases may also interest you

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

at 16:20
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...



News published on and distributed by: